BioDelivery Sciences International Inc. (BDSI) Company Profile
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. The BEMA technology is a small erodible polymer film for application to the buccal mucosa; and the Bioral cochleate drug delivery technology encapsulates a selected drug or therapeutic in a cochleate cylinder. Its pain franchise consists of products utilizing the patented BEMA technology, including ONSOLIS, a fentanyl buccal soluble film for the management of pain in opioid tolerant adult patients with cancer; and BEMA Buprenorphine, which is in the development stage for the treatment of moderate to severe chronic pain, as well as for the treatment of opioid dependence. The company also engages in developing product candidates utilizing the B EMA technology for conditions, such as nausea/vomiting. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
News about BDSI
Somewhat Favorable News Coverage Somewhat Unlikely to Impact BioDelivery Sciences International (BDS
Media headlines about BioDelivery Sciences International (NASDAQ:BDSI) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million b...Read More>>>
HighPoint Advisor Group LLC Buys Walmart Inc, Visa Inc, Waste Management Inc, Sells Walgreens Boots
Downers Grove, IL, based Investment company HighPoint Advisor Group LLC buys Walmart Inc, Visa Inc, Waste Management Inc, AbbVie Inc, Xilinx Inc, Marathon Oil Corp, Momo Inc, NVIDIA Corp, Halliburton Co, Welltower Inc, sells Walgreens Boots Alliance ...Read More>>>
BioDelivery Sciences International (BDSI) Price Target Cut to $3.50
BioDelivery Sciences International (NASDAQ:BDSI) had its target price reduced by research analysts at HC Wainwright from $4.00 to $3.50 in a research report issued to clients and investors on Wednesday. The brokerage currently has a “buy”...Read More>>>
Reader Inquiry: Financing Overhang Cleared For BioDelivery Sciences - What's Next?
Less than 2 weeks ago, I wrote a Reader Inquiry piece titled "At 52-Week Lows Is BioDelivery Sciences A Viable Turnaround Play?". The story was quite interesting, a case where the company possessed an asset with real value and yet leadership managed ...Read More>>>
Mid-Afternoon Market Update: Dow Turns Lower; J C Penney Shares Plunge
Toward the end of trading Thursday, the Dow traded down 0.16 percent to 24,729.12 while the NASDAQ declined 0.12 percent to 7,389.42. The S&P also fell, dropping 0.01 percent to 2,722.25. Leading and Lagging Sectors Thursday afternoon, the energ...Read More>>>